Where does Frederick Jones work?

Frederick Jones is Partner at BioAdvance.

What check size does Frederick Jones write?

Frederick Jones typically writes checks of $1.5M – $5M.

Where did Frederick Jones go to school?

Frederick Jones studied at University of Pennsylvania; The Wharton School (MBA); University of Pennsylvania School of Medicine (MD).

Frederick Jones

Investor

Partner at BioAdvance

Pennsylvania

Writes $1.5M – $5M checks · typically $3.3M

Find your path to Frederick

475 people in our graph share verified history with Frederick — schools, employers, funds. One of them is your warm intro.

Erica VanunlockedFrederick: together at Stealth Startup (2026)

×7Frederick: together at Stealth Startup

×2Frederick: together at Wyeth Pharmaceuticals

×2Frederick: together at University of Pennsylvania School of Medicine

About

Physician, executive and investor with 30+ years in life sciences, responsible for therapeutics and medical device investments at BioAdvance. Formerly a director at Broadview Ventures and CEO of Anchor Therapeutics.

Contact· self-published, not guessed

f•••@bioadvance.comreveal

Experience

Stealth StartupCo-Founder and CEOcurrent2026 — presentPhiladelphia, Pennsylvania, United States
BioAdvanceAdvisory Partnercurrent2024 — presentGreater Philadelphia
BioAdvancePartner2018 — 2024Greater Philadelphia
3 Degree Consulting LLCPrincipalcurrent2024 — presentPhiladelphia, Pennsylvania, United States
Broadview Ventures IncDirector2014 — 2017Greater Boston
Independent ConsultantBusiness Development and Operations Professional2012 — 2014Greater Boston
Anchor TherapeuticsCEO2008 — 2011
DevgenHead, Pharma Business Unit2007 — 2008
BioRexis (Pfizer)VP, Business Development2004 — 2007
Wyeth PharmaceuticalsAVP, Global Business Development2000 — 2004
Wyeth PharmaceuticalsSr. Director, Global Medical Affairs1997 — 2000
University of Pennsylvania School of MedicineAssistant Professor, Division of General Internal Medicine1994 — 1997

Skills & more

CEOBusiness DevelopmentBusiness StrategyTeam BuildingBiotechnologyCommercializationStart-upsBiochemistryMergers & AcquisitionsDrug DiscoveryDue DiligenceBiopharmaceuticals

+12 more

Clinical DevelopmentLicensingCorporate DevelopmentLifesciencesDrug DevelopmentPharmaceutical IndustryStrategyR&DMolecular BiologyTechnology TransferVenture CapitalMedical Devices

From Frederick's professional profile.

Investments

Investor

Aeromics, LLCAggamin BiologicsIschemia Care Remedy PharmaceuticalsZZ Biotech

Per curated public sources.

Colleagues at BioAdvance

Adam Glasofer

Entrepreneur-in-Residence at BioAdvance

David Shin

Partner at BioAdvance

Gayle Mineo

Office Management at BioAdvance

Gregory Harriman

Partner at BioAdvance

Jeff Edelson

Entrepreneur-in-Residence at BioAdvance

Jen Gilburg

Board of Directors; Deputy Secretary, Office of Technology & Entrepreneurship, PA DCED at BioAdvance

Jonathan Epstein

Board of Directors; Dean of the School of Medicine and EVP of the Health System, University of Pennsylvania at BioAdvance

Marie Lindner

Entrepreneur-in-Residence at BioAdvance

Frequently asked questions

Who is Frederick Jones?: Physician, executive and investor with 30+ years in life sciences, responsible for therapeutics and medical device investments at BioAdvance. Formerly a director at Broadview Ventures and CEO of Anchor Therapeutics.
Where does Frederick Jones work?: Frederick Jones is Partner at BioAdvance.
What check size does Frederick Jones write?: Frederick Jones typically writes checks of $1.5M – $5M.
What companies has Frederick Jones invested in?: Investments tracked here include Aeromics, LLC, Aggamin Biologics, Ischemia Care, Remedy Pharmaceuticals, ZZ Biotech.
Where did Frederick Jones go to school?: Frederick Jones studied at University of Pennsylvania; The Wharton School (MBA); University of Pennsylvania School of Medicine (MD).

Same school

Also attended University of Pennsylvania1,419

Brian ActonCo-founder of WhatsApp; co-founder of Signal Foundation Kunal BahlCo-founder of Snapdeal; co-founder of Titan Capital Dasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychology Nancy WangInvestor at Felicis Ventures Leah von SiemensPartner at Manta Ray Ventures Eghosa OmoiguiFounder and Managing General Partner at EchoVC Partners

+ 1,413 more

Also attended The Wharton School2,000

Sarah GuoFounder & General Partner of Conviction Josh KopelmanFounder and Partner at First Round Capital Aydin SenkutFounder & Managing Partner at Felicis Jack AbrahamFounder, CEO & Managing Partner of Atomic Katie RiesterPartner, Head of Investor Relations at Felicis Ventures Trevor OelschigInvestment Team at General Catalyst

+ 1,994 more

Also attended University of Pennsylvania School of Medicine57

René KuijtenInvestor at LSP (Life Sciences Partners)Jun JeonInvestor at Khosla Ventures Eric ShanAssociate at 7wire Ventures Seth GlickmanDigital Health Advisor at Excelerate Health Ventures Jonathan LeffExecutive Partner, Private Equity at Sofinnova Ventures Aaron NelsonPartner at Novo Holdings

+ 51 more

Shared employers

Also worked at Stealth Startup486

Andrew ChenGeneral Partner at Andreessen Horowitz Gabriel PereyraCo-founder & President of Harvey Erica VanInvestment Director at Intel Capital HemamAdvisor at Clear Ventures Arhaan A.Deeptech Fellow at Clear Ventures Hamish GarnettAssociate at Manta Ray Ventures

+ 480 more

Also worked at Broadview Ventures Inc13

Christopher ColecchiManaging Director at Broadview Ventures Christopher de SouzaDirector at Broadview Ventures Benjamin KreitmanPrincipal at Broadview Ventures Thomas NeedhamDirector, Head of the Biopharma Practice at Broadview Ventures Daniel GottliebDirector at Broadview Ventures Hewmun LauPrincipal at Broadview Ventures

+ 7 more

Also worked at Devgen3

Roel BulthuisInvestor at Syncona Wim Van CriekingeCo-Founder / Managing Director at Novalis Biotech Philippe VerwaerdePresident & Chief Science Officer at AlzProtect

Also worked at Wyeth Pharmaceuticals402

Jigar RaythathaInvestor at Third Rock Ventures Abbie CelnikerInvestor at Third Rock Ventures Erin MooreInvestor at Third Rock Ventures Jeb KeiperInvestor at Third Rock Ventures Richard ChesworthInvestor at Third Rock Ventures Michael TaylorOperating Partner at Mission Biocapital

+ 396 more